Cargando…
Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
Only approximately 50% of all familial breast cancers can be explained by known genetic factors, including mutations in BRCA1 and BRCA2. One of the most extensively studied candidates for breast and/or ovarian cancer susceptibility is BARD1. Although it was suggested that large mutations may contrib...
Autores principales: | Klonowska, Katarzyna, Ratajska, Magdalena, Czubak, Karol, Kuzniacka, Alina, Brozek, Izabela, Koczkowska, Magdalena, Sniadecki, Marcin, Debniak, Jaroslaw, Wydra, Dariusz, Balut, Magdalena, Stukan, Maciej, Zmienko, Agnieszka, Nowakowska, Beata, Irminger-Finger, Irmgard, Limon, Janusz, Kozlowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439969/ https://www.ncbi.nlm.nih.gov/pubmed/25994375 http://dx.doi.org/10.1038/srep10424 |
Ejemplares similares
-
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012) -
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
por: Koczkowska, Magdalena, et al.
Publicado: (2018) -
Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
por: Ratajska, Magdalena, et al.
Publicado: (2014) -
BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
por: Pilyugin, Maxim, et al.
Publicado: (2021) -
Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016)